Snoretox Ltd Overview
- Headquarters
- Victoria, Au
- Website
- snoretox.com
- Industry
- Biotechnology Research
- Employees
- 8
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Snoretox Ltd
In collaboration with RMIT University, Snoretox is developing the world’s first injectable solution to treat obstructive sleep apnoea and other conditions involving low muscle tone. Our game-changing technology is based on molecules of tetanus toxin, modified to ensure they work around the tetanus vaccine. Just as Botox uses tiny amounts of botulinum toxin to relax muscles, our prototype therapeutic uses minute amounts of safe modified tetanus toxin to achieve the opposite effect – muscle toning.
Snoretox Ltd Contact Details
- People in AeroLeads
- 3
Snoretox Ltd Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Thomas Mclean | Head of Innovation at Snoretox Ltd | Greater Melbourne Area, Australia |
View
|
| Kelly Makarounas-Kirchmann, Gaicd | Kmc Health Care | Greater Melbourne Area, Australia |
View
|
| Dr Dennis Feeney | Chair Venture Technology Group (Vtg) |
View
|
Employees by Management Level
Individual contributor
2 profiles
VP / Head
1 profile
Compare Similar Companies to Snoretox Ltd
ArthroLase
Medical Equipment Manufacturing
Ovum AI
Technology, Information And Media
eQcell Inc.
Biotechnology Research
Misti
Biotechnology
Invion Limited
Biotechnology Research
Tessara Therapeutics
Biotechnology Research
OneCup AI
Software Development
Peptidus Biotech
Biotechnology Research
AdraCard
Medical Equipment Manufacturing
ASTRA Therapeutics
Biotechnology